iMedicus.ca

What is iMedicus?

iMedicus is Canada’s most innovative livestream CME channel for specialists and family physicians!

Watch Now!

Hyperkalemia management in Heart Failure - Watch Now!

The New HFrontier: Watch Now!

The New HFrontier: Worsening Heart Failure

featured

11:26

Diabetes Update 2022 Podcast Series

Let’s Be Friends: A Collaborative Conversation between Endocrinology and Cardiology

59:51

A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in C

A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in CKD

03:02

AIM-LO: Statins + Ezetimibe

03:37

AIM-LO: LDL-C: Lower for Longer is Better

06:18

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data

03:03

AIM-LO: Icosapent ethyl (IPE)

06:14

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action

03:14

AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients

04:48

AIM-LO: Engaging With Your Patients about Selection of Injectable Therapies for

Engaging With Your Patients about Selection of Injectable Therapies for LDL-C Reduction

Diabetes Update 2023 Podcast Series

Optimal Treatment of Lipids: Who and When?

on demand

59:51

A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in C

A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in CKD

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Dosing FAQs

03:02

AIM-LO: Statins + Ezetimibe

03:37

AIM-LO: LDL-C: Lower for Longer is Better

06:18

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data

03:03

AIM-LO: Icosapent ethyl (IPE)

06:14

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action

03:14

AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients

04:48

AIM-LO: Engaging With Your Patients about Selection of Injectable Therapies for

Engaging With Your Patients about Selection of Injectable Therapies for LDL-C Reduction

03:14

AIM-LO: Overview of 2021 CCS Dyslipidemia Guidelines: Focus Secondary Prevention

AIM-LO: Overview of 2021 CCS Dyslipidemia Guidelines: Focus on Secondary Prevention

listen now

11:26

Diabetes Update 2022 Podcast Series

Let’s Be Friends: A Collaborative Conversation between Endocrinology and Cardiology

Diabetes Update 2023 Podcast Series

Optimal Treatment of Lipids: Who and When?

Diabetes Update 2023 Podcast Series

Is it Time to look at Time in Range?

Diabetes Update 2022 Podcast Series

Exploring Treatment Strategies for Diabetic Kidney Disease

11:59

Diabetes Update 2022 Podcast Series

Early Initiation of GLP-1RAs in the Continuum of Care

12:45

Diabetes Update 2022 Podcast Series

Management of Type I Diabetes in Pregnancy

13:33

Diabetes Update 2022 Podcast Series

Incorporating Novel Cardiovascular (Cv) Risk Reduction Strategies for Diabetes Patients: W

11:47

Diabetes Update 2022 Podcast Series

Does IT make a difference?

What is iMedicus?

Watch Now!

The New HFrontier: Watch Now!

featured

Diabetes Update 2022 Podcast Series

A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in C

AIM-LO: Statins + Ezetimibe

AIM-LO: LDL-C: Lower for Longer is Better

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data

AIM-LO: Icosapent ethyl (IPE)

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action

AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients

AIM-LO: Engaging With Your Patients about Selection of Injectable Therapies for

Diabetes Update 2023 Podcast Series

on demand

A Nephro and Cardio Convo: Common Clinical Questions around Anticoagulation in C

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Dosing FAQs

AIM-LO: Statins + Ezetimibe

AIM-LO: LDL-C: Lower for Longer is Better

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Efficacy & Safety Data

AIM-LO: Icosapent ethyl (IPE)

AIM-LO: PCSK9 inhibition (mAbs and siRNA) - Mechanisms of Action

AIM-LO: Key Tips to Maximize Therapeutic Access for Your Patients

AIM-LO: Engaging With Your Patients about Selection of Injectable Therapies for

AIM-LO: Overview of 2021 CCS Dyslipidemia Guidelines: Focus Secondary Prevention

listen now

Diabetes Update 2022 Podcast Series

Diabetes Update 2023 Podcast Series

Diabetes Update 2023 Podcast Series

Diabetes Update 2022 Podcast Series

Diabetes Update 2022 Podcast Series

Diabetes Update 2022 Podcast Series

Diabetes Update 2022 Podcast Series

Diabetes Update 2022 Podcast Series

Top 3 Conundrums in HF Podcasts (Spotify)

Top 3 Conundrums in HF Podcasts (Apple Podcasts)